Page 6 of 24

PA2.4-5 | Cell Death — Necrosis, Apoptosis, Gangrene & Calcification — SDL Guide (Part 2)

Apoptosis: Definition, Morphology, and Significance

A four-panel medical education diagram shows the morphologic sequence of apoptosis, its non-inflammatory mechanism, comparison with necrosis, and physiologic and pathologic significance. — **Panel A:** Healthy cell, cell shrinkage, chromatin condensation, intact nuclear membrane initially, nuclear fragmentation, membrane blebbing, apoptotic bodies, macrophage phagocytosis. **Panel B:** Intact plasma membrane, compact cytoplasm, intact organelles, phosphatidylserine externalization, macrophage receptor recognition, no lysosomal enzyme release, no inflammation. **Panel C:** Apoptosis with shrinkage and membrane-bound apoptotic bodies versus necrosis with cell swelling, membrane rupture, enzyme leakage, and neutrophil inflammation. **Panel D:** Physiologic apoptosis in digit separation, thymic negative selection, endometrial shedding, and post-partum breast involution; pathologic apoptosis in viral injury or DNA damage.

Apoptosis (Greek: apo = away, ptosis = falling — like leaves falling from a tree) is a form of programmed cell death in which the cell activates an intrinsic suicide programme. Unlike necrosis, apoptosis is highly regulated, energy-dependent, and does not elicit an inflammatory response.

Morphological hallmarks of apoptosis:
• Cell shrinkage — cytoplasm condenses; organelles remain intact but are compacted.
• Chromatin condensation (pyknosis) — chromatin aggregates beneath the nuclear envelope in a crescent or cap pattern; unlike necrotic pyknosis, the nuclear membrane remains intact initially.
• Nuclear fragmentation — condensed chromatin breaks into discrete fragments (compare: karyorrhexis in necrosis is random fragmentation).
• Formation of apoptotic bodies — the cell blebs and fragments into membrane-bound vesicles containing intact organelles and nuclear fragments.
• Phagocytosis by neighbouring cells or macrophages — apoptotic bodies are rapidly recognised (by phosphatidylserine flipped to the outer leaflet) and engulfed. No lysosomal enzyme release → no inflammation.

Physiologic apoptosis (normal, essential):
• Embryological morphogenesis (digit separation, neural tube closure)
• Thymic negative selection (deletion of autoreactive T cells)
• Endometrial shedding (menstruation)
• Regression of lactating breast post-partum

Pathologic apoptosis:
• Viral hepatitis (Councilman / acidophil bodies — apoptotic hepatocytes)
• Radiation and chemotherapy-induced tumour cell death (desired)
• Excessive apoptosis in neurodegenerative disease (Parkinson's, Alzheimer's)
• Deficient apoptosis in cancer (BCL-2 overexpression in follicular lymphoma)

Apoptosis Pathways — Intrinsic and Extrinsic

Diagram comparing intrinsic mitochondrial and extrinsic death receptor apoptosis pathways converging on executioner caspases and apoptotic body formation. — **Panel A:** Intrinsic mitochondrial pathway showing DNA damage, hypoxia, p53 activation, BAX, BAK, BIM, PUMA, NOXA, BCL-2, BCL-XL, MCL-1, mitochondrial outer membrane permeabilisation, cytochrome c release, APAF-1, ATP, apoptosome, caspase-9, and executioner caspases-3/6/7.. **Panel B:** Extrinsic death receptor pathway showing cytotoxic T lymphocyte or activated Th1 cell, FasL, Fas/CD95, TNF, TNFR1, receptor trimerisation, FADD, initiator caspase-8, and initiator caspase-10.. **Panel C:** Convergence panel showing caspase-9 and caspase-8/-10 activating executioner caspases-3/6/7, followed by chromatin condensation, cell shrinkage, membrane blebbing, apoptotic bodies, and phagocytosis without inflammation..

Both pathways converge on activation of caspases — a family of cysteine proteases that execute the cell death programme. Caspases exist as inactive pro-caspases; their sequential activation forms a cascade.

Intrinsic (mitochondrial) pathway:
• Triggers: DNA damage (radiation, chemotherapy), hypoxia, growth factor withdrawal, oncogene activation, oxidative stress.
• Sensors: tumour suppressor p53 senses DNA damage → transcribes pro-apoptotic BCL-2 family members (BAX, BAK, BIM, PUMA, NOXA).
• BCL-2 family balance (master regulator):
— Pro-apoptotic: BAX, BAK (form mitochondrial pores)
— Anti-apoptotic: BCL-2, BCL-XL, MCL-1 (block pore formation)
— BH3-only sensors: BIM, PUMA, NOXA (neutralise anti-apoptotic members when the cell is stressed)
• When BAX/BAK exceed BCL-2/BCL-XL: outer mitochondrial membrane permeabilisation → release of cytochrome c into cytosol.
• Cytochrome c + APAF-1 + ATP → apoptosome → activates initiator caspase-9 → cleaves and activates executioner caspases-3/6/7.

Extrinsic (death receptor) pathway:
• Triggers: immune surveillance; physiological deletion of lymphocytes; cytotoxic T-lymphocyte killing.
• Key receptor: Fas (CD95) on target cell surface; ligand: FasL on cytotoxic T cell or activated Th1 cell.
• Also: TNF receptor 1 (TNFR1) bound by TNF.
• Receptor trimerisation → recruitment of FADD (Fas-associated death domain) → recruitment and auto-activation of initiator caspase-8 (or -10) → activates executioner caspases-3/7.
• In some cells (Type II, e.g. hepatocytes): caspase-8 also cleaves BID → truncated BID (tBID) amplifies signal through the intrinsic pathway.

Executioner phase (shared):
Caspases-3/6/7 activate:
• CAD (caspase-activated DNase) → internucleosomal DNA fragmentation (ladder on gel)
• Cytoskeletal/nuclear protein cleavage → blebbing, condensation
• Flippase inhibition → phosphatidylserine externalisation → eat-me signal

Diagram of intrinsic mitochondrial and extrinsic Fas-mediated apoptosis pathways converging on caspases-3 and -7, with tBID cross-talk and BCL-2 overexpression blocking apoptosis. — **Panel A:** Intrinsic pathway: cellular stress, BCL-2 inhibition, BAX/BAK activation, mitochondrial outer membrane permeabilisation, cytochrome c release, Apaf-1 apoptosome, caspase-9; extrinsic pathway: FasL, Fas/CD95, FADD, caspase-8; cross-talk: BID cleavage to tBID activating BAX/BAK; convergence: executioner caspases-3/7 causing DNA fragmentation, membrane blebbing, apoptotic bodies, and phagocytosis without inflammation; clinical callout: t(14;18) causing BCL-2 overexpression and resistance to apoptosis..

SELF-CHECK

In follicular lymphoma, the t(14;18) translocation juxtaposes BCL-2 to the immunoglobulin heavy-chain locus, causing BCL-2 overexpression. What is the direct consequence for the lymphoma cells?

A. Increased mitosis — cells divide faster

B. Activation of caspase-9 — cells undergo spontaneous apoptosis

C. Resistance to apoptosis — cells accumulate because they cannot die

D. Loss of phosphatidylserine — cells evade phagocytosis

Reveal Answer

Answer: C. Resistance to apoptosis — cells accumulate because they cannot die

BCL-2 is an anti-apoptotic protein that blocks mitochondrial outer membrane permeabilisation and cytochrome c release. Overexpression suppresses the intrinsic pathway even when pro-apoptotic signals are present — the lymphoma cells simply accumulate rather than proliferating rapidly (BCL-2 does not drive proliferation). Option A is wrong: BCL-2 overexpression confers survival, not proliferative drive. Option B is the opposite: BCL-2 overexpression blocks, not activates, caspase-9. This is the classic teaching point: BCL-2-positive follicular lymphoma is typically slow-growing but incurable because normal cell turnover is abolished.

Necrosis vs Apoptosis — The High-Yield Comparison

Side-by-side medical diagram comparing necrosis and apoptosis by cell size, nuclear changes, membrane integrity, inflammation, and pattern of cell involvement. — **Panel A:** Necrosis: pathological stimulus, groups of swollen cells, oncosis, early membrane rupture, leaked cellular contents, neutrophilic inflammation, pyknosis, karyorrhexis, karyolysis.. **Panel B:** Apoptosis: physiological or pathological stimulus, single shrunken cell, intact membrane blebs, apoptotic bodies, crescent chromatin condensation, regular nuclear fragmentation, macrophage phagocytosis, no inflammation.. **Bottom strip:** High-yield comparison icons for stimulus, occurrence, cell size, nuclear change, membrane integrity, and inflammatory response..

The necrosis–apoptosis distinction is a guaranteed exam question. Master this table.

Feature	Necrosis	Apoptosis
Stimulus	Pathological (ischaemia, toxins, infection)	Physiological OR pathological
Occurrence	Groups of cells	Single cells or small clusters
Cell size	Swollen (oncosis)	Shrunken
Nucleus	Pyknosis → karyorrhexis → karyolysis	Fragmentation (regular pattern), crescent condensation
Membrane integrity	Lost early → contents leak	Maintained until apoptotic bodies form
Cytoplasm	Eosinophilic, vacuolated, dissolves	Condensed, intact organelles
Apoptotic bodies	Absent	Present (membrane-bound)
Inflammation	Prominent (DAMP release)	Absent (rapid phagocytosis, no DAMP release)
Energy requirement	Passive — no ATP needed	Active — requires ATP
Reversibility	Never once committed	Up to a late point (BCL-2 can block)
Clinical example	MI, infarct, abscess	Embryogenesis, thymic selection, viral hepatitis

IMPORTANT: One reliable exam trick: the question describes "single cells surrounded by normal cells, no inflammation" → apoptosis. "Large zone of dead cells with neutrophil infiltrate" → necrosis.

Side-by-side H&E-style histology comparison showing isolated apoptotic hepatocytes without inflammation versus myocardial necrosis with ghost fibers and neutrophil infiltration. — **Panel A:** Apoptosis in liver: shrunken apoptotic hepatocyte, dense pyknotic nucleus, intact neighboring hepatocytes, absence of inflammation. **Panel B:** Coagulative necrosis in myocardium: large necrotic zone, ghost myocardial fibers, loss of nuclei, neutrophil infiltrate.